Thromboembolic events with paclitaxel.
Chan
A T
AT
Yeo
W
W
Leung
W T
WT
Johnson
P J
PJ
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002544:Cerebral Infarction / Q000139:chemically induced*; D004155:Diphenhydramine / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects*; D011292:Premedication; D012640:Seizures / Q000139:chemically induced*
D000972:Antineoplastic Agents, Phytogenic; D006634:Histamine H1 Antagonists; D004155:Diphenhydramine; D017239:Paclitaxel